Peri-operative Reparixin therapy resulted in 50% 5-year insulin independence rate: The University of Chicago experience.
Ogledzinski M, Bachul PJ, Rezania K, Hariprasad SM, Gondek S, Lin W, Juengel B, Milejczyk K, Basto L, Wang LJ, Perea L, Tibudan M, Barth RN, Fung JJ, Witkowski P.
Ogledzinski M, et al. Among authors: tibudan m.
Clin Transplant. 2023 May;37(5):e14981. doi: 10.1111/ctr.14981. Epub 2023 Apr 4.
Clin Transplant. 2023.
PMID: 37013956
No abstract available.